Evidence map›Paper›PMID 38348117›Full record

ArticleFrontiers in oncology2023

MR imaging-based risk stratification scoring system to predict clinical outcomes in carotid body tumors.

Abhishek Mahajan, Atif Shaikh, Shreya Shukla, Richa Vaish, Ujjwal Agarwal, Vasundhara Smriti, Shivam Rastogi, Shonal Deokar, Shubham Suryavanshi, Pankaj Chaturvedi and 12 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Abhishek MahajanDepartment of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.
Atif ShaikhDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Shreya ShuklaDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Richa VaishDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Ujjwal AgarwalDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Vasundhara SmritiDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Shivam RastogiDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Shonal DeokarDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Shubham SuryavanshiDepartment of Radiology, Tata Memorial Hospital, Mumbai, India.
Pankaj ChaturvediDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Sarbani Ghosh LaskarDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Vijay PatilDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Nandini MenonDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Prathamesh PaiDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Gouri PantvaidyaDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Swapnil Ulhas RaneDepartment of Pathology, Tata Memorial Hospital, Mumbai, India.
Munita BalDepartment of Pathology, Tata Memorial Hospital, Mumbai, India.
Neha MittalDepartment of Pathology, Tata Memorial Hospital, Mumbai, India.
Asawari PatilDepartment of Pathology, Tata Memorial Hospital, Mumbai, India.
Anil Keith DcruzDepartment of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aims to evaluate the role of pretherapy MRI in predicting outcomes in carotid body tumors and propose a grading system for high- and low-risk characteristics. Materials and methods: A retrospective observational study of 44 patients with 51 lesions was carried out from year 2005 to 2020. MR images were reviewed for characteristics of carotid body tumor, and a score was given that was correlated with intra- and postoperative findings. The various other classifications and our proposed Mahajan classification were compared with Shamblin's classification. The area under the curve and ROC curves were used to present the accuracy of different predictive models. Results: Our scoring system allotted a score of 0 to 15 on the basis of MRI characteristics, with scores calculated for patients in our study ranging from 0 to 13. Lesions with scores of 0-6 were considered low risk (45%), and scores of 7-15 were regarded as high risk for surgery (55%). The Mahajan classification stages tumors into four grades: I (10%), II (20%), IIIa (8%), and IIIb (62%). The frequency of vascular injury was 50% in category I and 64% in category IIIb. The frequency of cranial nerve injury was 50%, 66%, and 27% in categories I, II, and IIIb. Conclusion: The Mahajan classification of CBTs evaluates high-risk factors like the distance of the tumor from the skull base and the angle of contact with ICA, which form the major predictors of neurovascular damage and morbidity associated with its surgery. Though the Shamblin classification of CBT is the most widely accepted classification, our proposed Mahajan classification system provides an imaging-based alternative to prognosticate surgical candidates preoperatively.

Indexed as

angle of contactcarotid body tumordistance from skull basemagnetic resonance imagingparagangliomascoringShamblin classification

Identifiers

PMID38348117
PMCPMC10860202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.